tirzepatide injection how to use video Inject + B12 for Weight Loss: Dr. Sheila Nazarian’s Doctor-Approved Guide Close-up view of a hand

Due to the increasing use of GLP-1RA in T2DM, the potential impact of adverse effects deserves concern

SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease

The most common adverse events reported by those on tirzepatide compared with placebo, respectively, were diarrhea (18.4% vs 6.3%), nausea (17.0% vs 6.5%), and constipation (14.8% vs 6%)

Supply gets steadier, since a pill you can run off in ordinary factories is much harder to run short of than an injectable peptide

Side effect counselling, injection technique, drug interactions and sharps disposal are all pharmacist responsibilities and patient touchpoints